A series of 5-(piperidinylethyloxy)quinoline 5-HT(1) receptor ligands have been studied by elaboration of the series of dual 5-HT(1)-SSRIs reported previously. These new compounds display a different in vitro pharmacological profile with potent affinity across the 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptors and selectivity against the serotonin transporter. Furthermore, they have improved pharmacokinetic profiles and CNS penetration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2008.11.052 | DOI Listing |
Publication Analysis
Top Keywords
5-ht1 receptor
8
studies series
4
series potent
4
potent orally
4
orally bioavailable
4
bioavailable 5-ht1
4
receptor ligands--part
4
ligands--part series
4
series 5-piperidinylethyloxyquinoline
4
5-piperidinylethyloxyquinoline 5-ht1
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!